BARDA Securing Anthrax Immunity For the Elderly

NCT03518125 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

305

Enrollment

FED

Sponsor class

Conditions

Anthrax

Interventions

BIOLOGICAL: BioThrax
BIOLOGICAL: AV7909
DRUG: Sodium chloride injection USP, 0.9% (placebo)

Sponsor

Biomedical Advanced Research and Development Authority

Collaborators

[object Object]